narcolepsy - HEALTHIES
Yahoo Finance: Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of ... Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting Narcolepsy was linked to high blood pressure, hyperlipidemia, and diabetes on top of outright cardiovascular disease events in a retrospective cohort study. Notably, patients with narcolepsy started ...
Understanding the Context
Managed Healthcare Executive: Narcolepsy burden especially high for young patients | AMCP Annual 2026 The burden of living with narcolepsy is high, and it starts at a young age, according to Luis Ortiz, M.D., assistant professor of pediatrics at Johns Hopkins School of Medicine, l ... Managed Healthcare Executive: Updated diagnostic criteria for narcolepsy type 1 vs. type 2 | AMCP Annual 2026 The diagnostic criteria for narcolepsy type 1 have undergone some changes within the last few years, and it is important that physicians are kept up-to-date for their patients, ma ... Updated diagnostic criteria for narcolepsy type 1 vs.
Image Gallery
Key Insights
type 2 | AMCP Annual 2026 Business Insider: Do you have narcolepsy? Take this test to screen for symptoms of excessive daytime sleepiness Narcolepsy is a rare condition that will make someone fall asleep abruptly — even in the middle of the day during an activity. It's possible to treat narcolepsy and manage your symptoms with lifestyle ... Do you have narcolepsy? Take this test to screen for symptoms of excessive daytime sleepiness Amanda Myers is a senior at the University of Florida majoring in pre-veterinary studies.
Related Articles You Might Like:
untreated high blood pressure localized granuloma annulare fitness conventions near meFinal Thoughts
She is also a competitive weightlifter, and a speaker for Project Sleep's Rising Voices of Narcolepsy program. Yahoo Finance: Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch CEO Richard Pops said the company is entering what he described as a “really exciting year” as the orexin agonist field moves closer to commercialization in narcolepsy, with broader ambitions in other ... Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch Narcolepsy with cataplexy, now known as type 1 narcolepsy, is a chronic neurological disorder that affects a person’s sleep-wake cycle and involves muscle weakness. The condition can cause a person to ... As a sleep specialist, I find it incredibly rewarding to treat people with narcolepsy. It can be unnerving to be diagnosed with the disorder.
But it’s also a huge relief, because people finally know ... CNN: Life with narcolepsy: ‘It’s not a joke, it’s a very serious illness’ Life with narcolepsy: ‘It’s not a joke, it’s a very serious illness’